Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression

Journal of Investigative Dermatology

Volumn 128, Issue 1, 2008, Pages 175-187

  Kaufmann, William K ^a,b   Nevis, Kathleen R ^a   Qu, Pingping ^c   Ibrahim, Joseph G ^b,c   Zhou, Tong ^a   Zhou, Yingchun ^a   Simpson, Dennis A ^a   Helms Deaton, Jennifer ^a   Cordeiro Stone, Marila ^a,b   Moore, Dominic T ^b   Thomas, Nancy E ^a,b   Hao, Honglin ^a   Liu, Zhi ^a   Shields, Janiel M ^a   Scott, Glynis A ^d   Sharpless, Norman E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c IL   (United States)

^d UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A;

ALLELE; ARTICLE; BAYES THEOREM; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MELANOMA; ONCOGENE N RAS; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 37049030384     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700935     Document Type: Article

References (65)

1. Agapova LS, Volodina JL, Chumakov PM, Kopnin BP (2004) Activation of Ras-Ral pathway attenuates p53-independent DNA damage G2 checkpoint. J Biol Chem 279:36382-9
2. Alizadeh AA, Ross DT, Perou CM, van de Rijn M (2005) Towards a novel classification of human malignancies based on gene expression patterns. J Pathol 195:41-52
3. Alonso SR, Ortiz P, Pollan M, Perez-Gomez B, Sanchez L, Acuna MJ et al. (2004) Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 164:193-203
4. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-70
5. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N et al. (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-7
6. Bauer J, Bastian BC (2006) Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 19:40-9
7. Bekker-Jensen S, Lukas C, Kitagawa R, Melander F, Kastan MB, Bartek J et al. (2006) Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J Cell Biol 173:195-206
8. Bloethner S, Chen B, Hemminki K, Muller-Berghaus J, Ugurel S, Schadendorf D et al. (2005) Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. Carcinogenesis 26:1224-32
9. Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH (1999) A human Cds1-related kinase that functions downstream of ATM protein in the cellular response to DNA damage. Proc Natl Acad Sci USA 96:3745-50
10. Chudnovsky Y, Adams AE, Robbins PB, Lin Q, Khavari PA (2005) Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet 37:745-9
11. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr (2005) The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 103:2391-6
12. Daniotti M, Oggionni M, Ranzani T, Vallacchi V, Campi V, Di Stasi D et al. (2004) BRAF alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 23:5968-77
13. Demers GW, Foster SA, Halbert CL, Galloway DA (1994) Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc Natl Acad Sci USA 91:4382-6
14. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C et al. (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:638-42
15. Doherty SC, McKeown SR, McKelvey-Martin V, Downes CS, Atala A, Yoo JJ et al. (2003) Cell cycle checkpoint function in bladder cancer. J Natl Cancer Inst 95:1859-68
16. Eskandarpour M, Hashemi J, Kanter L, Ringborg U, Platz A, Hansson J (2003) Frequency of UV-inducible NRAS mutations in melanomas of patients with germline CDKN2A mutations. J Natl Cancer Inst 95:790-8
17. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96:357-63
18. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK (2002) Melanoma incidence and mortality among US whites, 1969-1999. JAMA 288:1719-20
19. Gibbs P, Brady BM, Robinson WA (2002) The genes and genetics of malignant melanoma. J Cutan Med Surg 6:229-35
20. Giglia-Mari G, Sarasin A (2003) TP53 mutations in human skin cancers. Hum Mutat 21:217-28
21. Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340:1341-8
22. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-13
23. Grafstrom E, Egyhazi S, Ringborg U, Hansson J, Platz A (2005) Biallelic deletions in INK4 in cutaneous melanoma are common and associated with decreased survival. Clin Cancer Res 11:2991-7
24. Gray-Schopfer VC, Cheong SC, Chong H, Chow J, Moss T, Abdel-Malek ZA et al. (2006) Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer 95:496-505
25. Haqq C, Nosrati M, Sudilovsky D, Crothers J, Khodabakhsh D, Pulliam BL et al. (2005) The gene expression signatures of melanoma progression. Proc Natl Acad Sci USA 102:6092-7
26. Heffernan TP, Simpson DA, Frank AR, Heinloth AN, Paules RS, Cordeiro-Stone M et al. (2002) An ATR- and Chk1-dependent S checkpoint inhibits replicon initiation following UVC-induced DNA damage. Mol Cell Biol 22:8552-61
27. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A et al. (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64:5270-82
28. Itoh T, Cado D, Kamide R, Linn S (2004) DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proc Natl Acad Sci USA 101:2052-7
29. Itoh T, O'Shea C, Linn S (2003) Impaired regulation of tumor suppressor p53 caused by mutations in the xeroderma pigmentosum DDB2 gene: mutual regulatory interactions between p48(DDB2) and p53. Mol Cell Biol 23:7540-53
30. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316-23
31. Kaufmann WK, Campbell CB, Simpson DA, Deming PB, Filatov L, Galloway DA et al. (2002) Degradation of ATM-independent decatenation checkpoint function in human cells is secondary to inactivation of p53 and correlated with chromosomal destabilization. Cell Cycle 1:210-9
32. Kaufmann WK, Heffernan TP, Beaulieu LM, Doherty S, Frank AR, Zhou Y et al. (2003) Caffeine and human DNA metabolism: the magic and the mystery. Mutat Res 532:85-102
33. Kaufmann WK, Wilson SJ (1994) G1 arrest and cell-cycle-dependent clastogenesis in UV-irradiated human fibroblasts. Mutat Res 314:67-76
34. Knauf JA, Ouyang B, Knudsen ES, Fukasawa K, Babcock G, Fagin JA (2006) Oncogenic RAS induces accelerated transition through G2/M and promotes defects in the G2 DNA damage and mitotic spindle checkpoints. J Biol Chem 281:3800-9
35. Kraemer KH, Herlyn M, Yuspa SH, Clark WH Jr, Townsend GK, Neises GR et al. (1989) Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosum. Arch Dermatol 125:263-8
36. Kumar R, Angelini S, Snellman E, Hemminki K (2004) BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 122:342-8
37. Marrot L, Belaidi JP, Jones C, Perez P, Meunier JR (2005) Molecular responses to stress induced in normal human Caucasian melanocytes in culture by exposure to simulated solar UV. Photochem Photobiol 81:367-75
38. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-4
39. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-5
40. Nambiar S, Mirmohammadsadegh A, Doroudi R, Gustrau A, Marini A, Roeder G et al. (2005) Signaling networks in cutaneous melanoma metastasis identified by complementary DNA microarrays. Arch Dermatol 141:165-73
41. Newton MA, Noueiry A, Sarkar D, Ahlquist P (2004) Detecting differential gene expression with a semiparametric hierarchical mixture method. Biostatistics 5:155-76
42. Noonan DM, Severino A, Morini M, Tritarelli A, Manente L, D'Agnano I et al. (2005) In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16(INK4A)-defective, pRb-positive human melanoma cells. J Cell Physiol 202:922-8
43. Paules RS, Levedakou EN, Wilson SJ, Innes CL, Rhodes N, Tlsty TD et al. (1995) Defective G2 checkpoint function in cell from individuals with familial cancer syndromes. Cancer Res 55:1763-73
44. Peng CY, Graves PR, Thoma RS, Wu Z, Shaw AS, Piwnica-Worms H (1997) Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216 [see comments]. Science 277:1501-5
45. Pho L, Grossman D, Leachman SA (2006) Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol 18:173-9
46. Puc J, Keniry M, Li HS, Pandita TK, Choudhury AD, Memeo L et al. (2005) Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7:193-204
47. Rogakou EP, Boon C, Redon C, Bonner WM (1999) Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146:905-16
48. Santana C, Ortega E, Garcia-Carranca A (2002) Oncogenic H-ras induces cyclin B1 expression in a p53-independent manner. Mutat Res 508:49-58
49. Satyamoorthy K, Chehab NH, Waterman MJ, Lien MC, El-Deiry WS, Herlyn M et al. (2000) Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells. Cell Growth Differ 11:467-74
50. Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL et al. (2003) Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 63:756-9
51. Scott G, Jacobs S, Leopardi S, Anthony FA, Learn D, Malaviya R et al. (2005) Effects of PGF2alpha on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res 304:407-16
52. Seykora JT, Jih D, Elenitsas R, Horng WH, Elder DE (2003) Gene expression profiling of melanocytic lesions. Am J Dermatopathol 25:6-11
53. Shields JM, Thomas NE, Cregger M, Berger AJ, Leslie M, Torrice C et al. (2007) Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma. Cancer Res 67:1502-12
54. Simpson DA, Livanos E, Heffernan TP, Kaufmann WK (2005) Telomerase expression is sufficient for chromosomal integrity in cells lacking p53 dependent G1 checkpoint function. J Carcinog 4:18
55. Smalley KS, Herlyn M (2004) Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions. J Invest Dermatol 123:xvi-i
56. Sun Y, Tran BN, Worley LA, Delston RB, Harbour JW (2005) Functional analysis of the p53 pathway in response to ionizing radiation in uveal melanoma. Invest Ophthalmol Vis Sci 46:1561-4
57. Thomas NE, Alexander A, Edmiston SN, Parrish E, Millikan RC, Berwick M et al. (2004) Tandem BRAF mutations in primary invasive melanomas. J Invest Dermatol 122:1245-50
58. Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H et al. (2007) Number of nevi and early life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomarkers Prev 16:991-7
59. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99:6567-72
60. Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS et al. (2006) Gene expression patterns associated with p53 status in breast cancer. BMC Cancer 6:276
61. Tsao H, Goel V, Wu H, Yang G, Haluska FG (2004) Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol 122:337-41
62. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-21
63. Wang QE, Zhu Q, Wani G, Chen J, Wani AA (2004) UV radiation-induced XPC translocation within chromatin is mediated by damaged-DNA binding protein, DDB2. Carcinogenesis 25:1033-43
64. Warters RL, Adamson PJ, Pond CD, Leachman SA (2005) Melanoma cells express elevated levels of phosphorylated histone H2AX foci. J Invest Dermatol 124:807-17
65. Zampetti-Bosseler F, Scott D (1981) Cell death, chromosome damage and mitotic delay in normal human, ataxia telangiectasia and retinoblastoma fibroblasts after X-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med 39:547-58